Education
AST podcasts and recordings
Podcasts
January 04, 2011
In this podcast, Dr. Veronica Gomez-Lobo, Professor of Clinical Ob/Gyn at Georgetown University School of Medicine and Director of Pediatric and Adolescent Ob/Gyn at Washington Hospital Center and Children's National Medical Center describe new methods of contraception as well as the new CDC Guidelines for contraceptive management in recipients of solid organ transplants.
December 29, 2010
In this podcast, Dr. Jagbir Gill, Assistant Professor of Medicine, Division of Nephrology at the University of British Columbia discusses issues related to kidney transplantation and post-transplant immunosuppressive management in the elderly patient with end stage renal disease.
December 28, 2010
In this podcast, Dr. Steven Gordon, Associate Professor of Medicine, Chairman of the Department of Infectious at the Cleveland Clinic describes the epidemiology of infections in patients with implantable ventricular assist devices (VAD) as bridge and reviews clinical approach to management and prevention of VAD associated infections.
December 23, 2010
In this podcast, Dr. Michele I. Morris, Associate Professor of Clinical Medicine, Clinical Chief of the Division of Infectious Diseases and Director of the Immunocompromised Host Section at the University of Miami Miller School of Medicine describes the importance of tuberculosis as a potential donor transmitted infection and reviews guidelines for evaluating donors and candidates.
October 26, 2010
In this podcast, Dr. Marian Michaels, Professor of Pediatrics and Surgery at Children's Hospital of Pittsburgh, interviews Dr. Deepali Kumar, Associate Professor ofInfectious Diseases at the University of Alberta, to address issues of influenza and influenza vaccination in the transplant community. They will discuss the effectiveness of the influenza vaccine in the transplant patients and recommendations for vaccinations. In addition, they will address the use of flumist in close contacts and healthcare workers. Issues of concern such as screening for influenza in our patients and instituting early treatment will be reviewed as well as other recommendations for keeping our patients healthy during the flu season.
September 28, 2010
Dr. Daniel Kaul, Director of the Transplant Infectious Disease services at the University of Michigan, discusses the changing paradigms for testing of Human T cell lymphotropic viruses. The podcast reviews HTLV disease and epidemiology. Dr. Kaul specifically explains the problems that we have with current testing for HTLV in a low prevalence area such as the United States and the rationale for UNOS deciding to discontinue Donor screening of HTLV.
July 15, 2010
In this podcast, Dr. Angela Maldonado, Clinical Assistant Professor of Pharmacotherapy at Washington State University and Kidney Transplant Pharmacist at Providence Sacred Heart Medical Center and Children's Hospital, discusses the clinical services pharmacists provide in the outpatient transplant clinic. Dr. Maldonado describes the regulatory requirements, typical work flow, billing practices, and resource requirements to establish these services.
June 15, 2010
In this podcast, Dr. Patrick Niaudet, Head of Pediatric Nephrology Department, Professor of Pediatrics, Hopital Necker-Enfants Malades, a current editor for Pediatric Nephrology of "UpToDate", and a participating Editor of "Pediatric Nephrology", 2009, together with Dr. Amira Al-Uzri, Medical Director of the Pediatric Kidney Transplant Program, Associate Professor of Pediatrics, Oregon Health and Science University, discuss the topic of recurrent focal segmental glomerulosclerosis (FSGS) post kidney transplantation in children. Dr. Niaudet gives a thorough overview of the incidence and risk factors associated with recurrent FSGS post kidney transplantation, the genetic abnormalities present in a subset of patients, and potential new treatment options.
April 28, 2010
In this podcast, Dr. Jens Goebel, Medical Director of Kidney Transplantation at Cincinnati Children's and Associate Professor of Pediatrics, University of Cincinnati College of Medicine and Dr. Alicia Neu, Medical Director of Pediatric Dialysis and Kidney Transplantation at the Johns Hopkins Hospital, discuss the issue of chronic kidney disease (CKD) in non-kidney transplant patients with an emphasis on pediatric patients. Dr. Goebel describes the limitations of current methods of measuring glomerular function rate, the typical causes of CKD and potential mechanisms to slow progression of CKD in this population.
March 30, 2010
In this podcast, Dr. Gregory E. Malat, Transplant Pharmacist Hahnemann University Hospital and Assistant Professor Drexel University School of Medicine, and Dr. Eric M Tichy, Clinical Pharmacist from the Yale-New Haven Transplantation Center, discuss the unique issues regarding management of drug interactions between transplant immunosuppressants and highly active antiretroviral therapy (HAART). Dr. Malat describes the components of HAART regimens, reviews the impact HAART medications have on immunosuppressant drug levels, and provides recommendations for management of these issues in the clinical transplant setting.
Pages
Podcasts
January 04, 2011
In this podcast, Dr. Veronica Gomez-Lobo, Professor of Clinical Ob/Gyn at Georgetown University School of Medicine and Director of Pediatric and Adolescent Ob/Gyn at Washington Hospital Center and Children's National Medical Center describe new methods of contraception as well as the new CDC Guidelines for contraceptive management in recipients of solid organ transplants.
December 29, 2010
In this podcast, Dr. Jagbir Gill, Assistant Professor of Medicine, Division of Nephrology at the University of British Columbia discusses issues related to kidney transplantation and post-transplant immunosuppressive management in the elderly patient with end stage renal disease.
December 28, 2010
In this podcast, Dr. Steven Gordon, Associate Professor of Medicine, Chairman of the Department of Infectious at the Cleveland Clinic describes the epidemiology of infections in patients with implantable ventricular assist devices (VAD) as bridge and reviews clinical approach to management and prevention of VAD associated infections.
December 23, 2010
In this podcast, Dr. Michele I. Morris, Associate Professor of Clinical Medicine, Clinical Chief of the Division of Infectious Diseases and Director of the Immunocompromised Host Section at the University of Miami Miller School of Medicine describes the importance of tuberculosis as a potential donor transmitted infection and reviews guidelines for evaluating donors and candidates.
October 26, 2010
In this podcast, Dr. Marian Michaels, Professor of Pediatrics and Surgery at Children's Hospital of Pittsburgh, interviews Dr. Deepali Kumar, Associate Professor ofInfectious Diseases at the University of Alberta, to address issues of influenza and influenza vaccination in the transplant community. They will discuss the effectiveness of the influenza vaccine in the transplant patients and recommendations for vaccinations. In addition, they will address the use of flumist in close contacts and healthcare workers. Issues of concern such as screening for influenza in our patients and instituting early treatment will be reviewed as well as other recommendations for keeping our patients healthy during the flu season.
September 28, 2010
Dr. Daniel Kaul, Director of the Transplant Infectious Disease services at the University of Michigan, discusses the changing paradigms for testing of Human T cell lymphotropic viruses. The podcast reviews HTLV disease and epidemiology. Dr. Kaul specifically explains the problems that we have with current testing for HTLV in a low prevalence area such as the United States and the rationale for UNOS deciding to discontinue Donor screening of HTLV.
July 15, 2010
In this podcast, Dr. Angela Maldonado, Clinical Assistant Professor of Pharmacotherapy at Washington State University and Kidney Transplant Pharmacist at Providence Sacred Heart Medical Center and Children's Hospital, discusses the clinical services pharmacists provide in the outpatient transplant clinic. Dr. Maldonado describes the regulatory requirements, typical work flow, billing practices, and resource requirements to establish these services.
June 15, 2010
In this podcast, Dr. Patrick Niaudet, Head of Pediatric Nephrology Department, Professor of Pediatrics, Hopital Necker-Enfants Malades, a current editor for Pediatric Nephrology of "UpToDate", and a participating Editor of "Pediatric Nephrology", 2009, together with Dr. Amira Al-Uzri, Medical Director of the Pediatric Kidney Transplant Program, Associate Professor of Pediatrics, Oregon Health and Science University, discuss the topic of recurrent focal segmental glomerulosclerosis (FSGS) post kidney transplantation in children. Dr. Niaudet gives a thorough overview of the incidence and risk factors associated with recurrent FSGS post kidney transplantation, the genetic abnormalities present in a subset of patients, and potential new treatment options.
April 28, 2010
In this podcast, Dr. Jens Goebel, Medical Director of Kidney Transplantation at Cincinnati Children's and Associate Professor of Pediatrics, University of Cincinnati College of Medicine and Dr. Alicia Neu, Medical Director of Pediatric Dialysis and Kidney Transplantation at the Johns Hopkins Hospital, discuss the issue of chronic kidney disease (CKD) in non-kidney transplant patients with an emphasis on pediatric patients. Dr. Goebel describes the limitations of current methods of measuring glomerular function rate, the typical causes of CKD and potential mechanisms to slow progression of CKD in this population.
March 30, 2010
In this podcast, Dr. Gregory E. Malat, Transplant Pharmacist Hahnemann University Hospital and Assistant Professor Drexel University School of Medicine, and Dr. Eric M Tichy, Clinical Pharmacist from the Yale-New Haven Transplantation Center, discuss the unique issues regarding management of drug interactions between transplant immunosuppressants and highly active antiretroviral therapy (HAART). Dr. Malat describes the components of HAART regimens, reviews the impact HAART medications have on immunosuppressant drug levels, and provides recommendations for management of these issues in the clinical transplant setting.
Pages
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.